
Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic
Author(s) -
Nan Wang,
Min Zhang,
Huajun Su,
Zhonglue Huang,
Yongbo Lin,
Min Zhang
Publication year - 2020
Publication title -
journal of international medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 57
eISSN - 1473-2300
pISSN - 0300-0605
DOI - 10.1177/0300060520966151
Subject(s) - medicine , fibrinolysis , myocardial infarction , percutaneous coronary intervention , thrombolysis , pandemic , cardiology , covid-19 , chest pain , tenecteplase , emergency medicine , intensive care medicine , disease , infectious disease (medical specialty)